This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

HDV-B

Diasome Pharmaceuticals

Drug Names(s): Injectable basal long acting insulin

Description: HDV-B compromises the imtermediate-acting and long-acting versions of injectable HDV-I and is designed to provide a once-per-day (or twice-per-day with intermediate-acting) insulin therapy.


HDV-B News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug